BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9611061)

  • 1. Venous port systems in the field of gynaecological oncology.
    Rauthe G; Altmann C
    Eur J Gynaecol Oncol; 1998; 19(2):173-8. PubMed ID: 9611061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complications in connection with venous port systems: prevention and therapy.
    Rauthe G; Altmann C
    Eur J Surg Oncol; 1998 Jun; 24(3):192-9. PubMed ID: 9630859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Complications of central venous and indwelling catheterization].
    Douard MC; Desruennes E; Kriegel I; Blot F
    Rev Prat; 2006 Jun; 56(12):1281-9. PubMed ID: 16948214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of mechanical malfunction in low-profile subcutaneous implantable venous access devices in patients receiving chemotherapy for gynecologic malignancies.
    Subramaniam A; Kim KH; Bryant SA; Kimball KJ; Huh WK; Straughn JM; Estes JM; Alvarez RD
    Gynecol Oncol; 2011 Oct; 123(1):54-7. PubMed ID: 21742372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Extravasation of cytostatics. Example of a severe complication from the use of long-term central venous catheters].
    Bach F; Videbaek C; Holst-Christensen J; Boesby S
    Ugeskr Laeger; 1991 Oct; 153(41):2896-7. PubMed ID: 1949309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Venous access ports: frequency and management of complications in oncology patients.
    Jordan K; Behlendorf T; Surov A; Kegel T; Maher G; Wolf HH
    Onkologie; 2008 Jul; 31(7):404-10. PubMed ID: 18596390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Update on implantable chambers].
    Nahum S
    Soins Gerontol; 2006; (61):17-20. PubMed ID: 17063848
    [No Abstract]   [Full Text] [Related]  

  • 8. Complications associated with an implantable vascular access device.
    Dillon PA; Foglia RP
    J Pediatr Surg; 2006 Sep; 41(9):1582-7. PubMed ID: 16952595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Complications associated with venous access devices: Part two.
    Hamilton H
    Nurs Stand; 2006 Mar 15-21; 20(27):59-65; quiz 66. PubMed ID: 16566340
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of central venous catheters in paediatric oncology--a cautionary tale.
    Russell L; Craig JI; Mackinlay GA; Eden OB
    Scott Med J; 1990 Feb; 35(1):11-4. PubMed ID: 2315681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Totally implantable venous-access ports: local problems and extravasation injury.
    Kurul S; Saip P; Aydin T
    Lancet Oncol; 2002 Nov; 3(11):684-92. PubMed ID: 12424071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A randomized, prospective trial of central venous ports connected to standard open-ended or Groshong catheters in adult oncology patients.
    Biffi R; De Braud F; Orsi F; Pozzi S; Arnaldi P; Goldhirsch A; Rotmensz N; Robertson C; Bellomi M; Andreoni B
    Cancer; 2001 Sep; 92(5):1204-12. PubMed ID: 11571734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retrospective evaluation of totally implantable venous access port devices: early and late complications.
    Gurkan S; Seber S; Gur O; Yetisyigit T; Okan Donbaloglu M; Ozkaramanli Gur D
    J BUON; 2015; 20(1):338-45. PubMed ID: 25778336
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral venous access ports: outcomes analysis in 109 patients.
    Bodner LJ; Nosher JL; Patel KM; Siegel RL; Biswal R; Gribbin CE; Tokarz R
    Cardiovasc Intervent Radiol; 2000; 23(3):187-93. PubMed ID: 10821892
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Central venous access catheters: radiological management of complications.
    Teichgräber UK; Gebauer B; Benter T; Wagner HJ
    Cardiovasc Intervent Radiol; 2003; 26(4):321-33. PubMed ID: 14667113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous removal of embolized port catheter: The standard option.
    Marcy PY; Thariat J; Amoretti N
    Catheter Cardiovasc Interv; 2008 Dec; 72(7):1025-6. PubMed ID: 19021275
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of venous port systems in oncology: a review of current evidence.
    Vescia S; Baumgärtner AK; Jacobs VR; Kiechle-Bahat M; Rody A; Loibl S; Harbeck N
    Ann Oncol; 2008 Jan; 19(1):9-15. PubMed ID: 17846025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete catheter disconnection and migration of an implantable venous access device: the disconnected cap sign.
    Faraj W; Zaghal A; El-Beyrouthy O; Kutoubi A
    Ann Vasc Surg; 2010 Jul; 24(5):692.e11-5. PubMed ID: 20413259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy drug extravasation in totally implantable venous access port systems: how effective is early surgical lavage?
    Azaïs H; Bresson L; Bassil A; Katdare N; Merlot B; Houpeau JL; El Bedoui S; Meurant JP; Tresch E; Narducci F
    J Vasc Access; 2015; 16(1):31-7. PubMed ID: 25362986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A totally implantable permanent central venous access, long-term experience with subcutaneous infusion chambers].
    Lorenz M; Hottenrott C; Seufert RM; Encke A
    Langenbecks Arch Chir; 1988; 373(5):302-9. PubMed ID: 3077420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.